Truvestments Capital LLC Acquires Shares of 6,989 Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Truvestments Capital LLC acquired a new stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 6,989 shares of the pharmacy operator’s stock, valued at approximately $63,000.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Independent Advisor Alliance boosted its holdings in shares of Walgreens Boots Alliance by 46.0% in the third quarter. Independent Advisor Alliance now owns 33,310 shares of the pharmacy operator’s stock worth $298,000 after acquiring an additional 10,492 shares during the period. Larson Financial Group LLC boosted its holdings in shares of Walgreens Boots Alliance by 49.9% in the third quarter. Larson Financial Group LLC now owns 9,803 shares of the pharmacy operator’s stock worth $88,000 after acquiring an additional 3,264 shares during the period. Pitcairn Co. bought a new position in shares of Walgreens Boots Alliance in the third quarter worth $159,000. Cerity Partners LLC boosted its holdings in shares of Walgreens Boots Alliance by 75.3% in the third quarter. Cerity Partners LLC now owns 672,104 shares of the pharmacy operator’s stock worth $6,022,000 after acquiring an additional 288,657 shares during the period. Finally, Great Valley Advisor Group Inc. bought a new position in shares of Walgreens Boots Alliance in the third quarter worth $106,000. 58.59% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on WBA shares. Morgan Stanley cut their price target on Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating for the company in a report on Friday, October 11th. TD Cowen dropped their price objective on Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating for the company in a research note on Tuesday, October 22nd. UBS Group lifted their price objective on Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a research note on Thursday, October 17th. JPMorgan Chase & Co. dropped their price objective on Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating for the company in a research note on Friday, August 30th. Finally, Truist Financial dropped their price objective on Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating for the company in a research note on Monday, October 7th. Four investment analysts have rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Walgreens Boots Alliance currently has an average rating of “Hold” and a consensus target price of $12.88.

View Our Latest Analysis on Walgreens Boots Alliance

Walgreens Boots Alliance Trading Up 3.8 %

NASDAQ WBA opened at $9.06 on Thursday. The company has a market capitalization of $7.83 billion, a price-to-earnings ratio of -0.91, a PEG ratio of 1.19 and a beta of 0.69. The stock’s 50-day simple moving average is $9.13 and its two-hundred day simple moving average is $11.37. The company has a quick ratio of 0.37, a current ratio of 0.68 and a debt-to-equity ratio of 0.67. Walgreens Boots Alliance, Inc. has a twelve month low of $8.08 and a twelve month high of $27.05.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last released its quarterly earnings data on Tuesday, October 15th. The pharmacy operator reported $0.39 EPS for the quarter, topping the consensus estimate of $0.36 by $0.03. The firm had revenue of $37.50 billion for the quarter, compared to the consensus estimate of $35.75 billion. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The company’s quarterly revenue was up 5.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.67 earnings per share. Research analysts forecast that Walgreens Boots Alliance, Inc. will post 1.53 EPS for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 12th. Stockholders of record on Monday, November 18th will be issued a $0.25 dividend. The ex-dividend date of this dividend is Monday, November 18th. This represents a $1.00 annualized dividend and a dividend yield of 11.04%. Walgreens Boots Alliance’s dividend payout ratio is currently -9.99%.

Walgreens Boots Alliance Company Profile

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Further Reading

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.